If a researcher discovers a novel compound that selectively inhibits cyclooxygenase-2 (COX-2) in activated macrophages, which consequence follows regarding inflammatory pathways?

💡 Explanation

Inhibiting COX-2 directly reduces prostaglandin E2 (PGE2) synthesis because COX-2 is the enzyme responsible for converting arachidonic acid into PGE2. Therefore, the correct answer is reduced prostaglandin E2, rather than increased cytokine production, NF-κB activation, or leukotriene formation.

• If a genetically modified T-cell with enhanced tumor recognition ability is infused into a patient, which consequence related to immune homeostasis is most likely to occur?
• If a researcher introduces a telomerase inhibitor to cells undergoing division in vitro, which consequence follows for chromosome stability?
• Why does aging cartilage exhibit reduced resilience under compressive loads, leading to increased osteoarthritis risk?
• Why does vasodilation occur in wet beriberi, leading to edema?
• If a patient has a mutation causing constitutive activation of thyroid stimulating hormone (TSH) receptors, why does thyroid hormone production not increase indefinitely?
• Why does collagen deposition in arteries increase with age?